Genesis Private Wealth’s CME Group CME Stock Holding History

Genesis Private Wealth’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-969	Closed	-$286K	–	194
2026 Q1	$286K	Buy	+969	New	+$288K	0.09%	131

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Genesis Private Wealth's CME Position: Q2 2026 in Review

Genesis Private Wealth sold out of CME Group (CME) in Q2 2026, closing a stake of 969 shares — an estimated $286K sold.

Genesis Private Wealth first reported a position in CME in Q1 2026 and held it in 1 quarter. The position peaked at $286K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Genesis Private Wealth reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Genesis Private Wealth sold 969 CME Group shares in Q2 2026, an estimated $286K.
Genesis Private Wealth first reported a position in CME Group in Q1 2026 and held it in 1 quarter.
Genesis Private Wealth's CME Group position peaked at $286K in Q1 2026.
1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.